Global Health Q1 FY26 Results (NSE: MEDANTA)
Signal: Margin pressure
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹130.41 Cr | 26.5% | 12.6% |
| EBIT | ₹109.17 Cr | 30.4% | |
| Net profit | ₹15.87 Cr | -0.1% | |
| EPS | ₹5.91 | -0.2% | |
| EBIT margin | 21.9% |
P&L walk
Strong revenue growth of +26.5% YoY was offset by structural cost increases: retainers & consultants (+47% YoY), depreciation (+53% YoY from new beds) and finance costs (+94% YoY), leaving PAT flat YoY despite the exceptional gain (₹196 Cr) in the year-ago quarter being absent.
Research and educational content only. Not investment advice.